hydroxychloroquine

Originally posted by kbear1: ↑

Gee, Flogging a Dead Horse really should be included as an Olympic sport.

You'd be a serious contender for the GOLD...@BugGold

1.

https://www.recoverytrial.net/

Oxford University
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19

2.

https://www.acpjournals.org/doi/10.7326/M20-4207 https://clinicaltrials.gov/ct2/show/NCT04308668

University of Minnesota, the University of Manitoba, and McGill University
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
A Randomized Trial

Of 491 patients randomly assigned to a group, 423 contributed primary end point data. Of these, 341 (81%) had laboratory-confirmed infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or epidemiologically linked exposure to a person with laboratory-confirmed infection; 56% (236 of 423) were enrolled within 1 day of symptoms starting.

Change in symptom severity over 14 days did not differ between the hydroxychloroquine and placebo groups (difference in symptom severity: relative, 12%; absolute, −0.27 points [95% CI, −0.61 to 0.07 points]; P = 0.117).

At 14 days, 24% (49 of 201) of participants receiving hydroxychloroquine had ongoing symptoms compared with 30% (59 of 194) receiving placebo (P = 0.21).

Medication adverse effects occurred in 43% (92 of 212) of participants receiving hydroxychloroquine versus 22% (46 of 211) receiving placebo
CONCLUSIONS
After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure.

3.

https://clinicaltrials.gov/ct2/show/NCT04304053
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19

A second large PEP trial has come up empty as well, its leader tellsScience. Carried out in Barcelona, Spain, thatstudyrandomized more than 2300 people exposed to the virus to either hydroxychloroquine or the usual care. There was no significant difference between the number of people in each group who developed COVID-19, says Oriol Mitjà of the Germans Trias i Pujol University Hospital.

.

Expand

It would appear the only flogging is the one you are giving yourself by repeatedly posting misrepresentations in context of the thread.

It shouldn't be a big ask if all, but we all know it is, and of course reasonable people wonder why

thus

"There is a gulf of difference between those presenting information in good faith and the big pharma guys on here.

One of these core differences seems to be the absolute reticence for these guys to produce any of the so called studies discrediting NCQ + its adjuvants within the parameters commonly ascribing to some success. All you get is reports of studies. You can almost put money on a link now being provided to one of the misrepresentative studies (well maybe not now that I mentioned it)

Sure, we know there are studies where people were OD'd, treated on their last legs (on ventilators etc), treated without the full co administrations and on and on. But where are the 'official' big pharma studies within the parameters. It cannot be a accidental oversight. (and yes I expect a 'So what are these parameters' obtuseness to present itself)"

So by all means continue your flogging, (hint, perhaps some carrots may act as a prophylactic for you) no one would expect otherwise.......